While many, if not most investors, appear bullish about the market’s prospects this year, it’s never a bad time to consider long-term dividend stocks. By that, we’re talking about profitable, relevant enterprises that you can trust. These aren’t necessarily sexy securities but they should help you ride out any turbulence or even outright storms.

Indeed, one of the main benefits of so-called unshakeable long-term dividend stocks centers on the psychological factor. So long as you’re targeting reliable entities with an established track record, you’re likely to get something. Even if your portfolio takes a hit, you can generally bank on passive income. Like in a game of football, it’s good to know you have a speedy free safety covering the zone behind you.

On a related note, long-term dividend stocks offer lower volatility compared to, say, the latest fad in technology. Usually, we’re dealing with leaders of industry. They’re in the maturity phase of their business cycle, meaning they command significant influence. They won’t provide the best growth potential but they’ll keep the ship afloat.

With that, below are long-term dividend stocks to consider.

Kenvue (KVUE)

Albuquerque, New Mexico / USA - November 2 2020: Boxes of Band-Aids in Walmart in the pharmacy and over-the-counter medication aisle. Kenvue (KVUE) split from JNJ and now owns the Band-aid brand.

Source: Giovanni Nastukov / Shutterstock.com

Spun off from pharmaceutical and medical technologies giant Johnson & Johnson (NYSE:JNJ), Kenvue (NYSE:KVUE) operates the consumer healthcare unit as a standalone business. It must be said that the performance following KVUE’s public market debut hasn’t been particularly encouraging. While shares may be down 19% in the past 52 weeks, they’ve been gradually marching higher since late October.

I expect this trend to continue. According to Precedence Research, the global consumer healthcare market size reached $284.16 billion in 2022. By 2032, the segment could hit $608.39 billion, representing a compound annual growth rate (CAGR) of 7.91%. Here, the advantage that Kenvue leverages is its brands like Band-Aid, Listerine, and Tylenol. In other words, we’re talking about brands that people know, people trust.

It’s also a very attractive idea for long-term dividend stocks, carrying a forward yield of 3.66%. Further, the payout ratio – while somewhat elevated – is acceptable at 59.27%. Unless you envision a future where no one gets the sniffles or boo-boos, you can trust KVUE.

Sempra (SRE)

The logo for Sempra (SRE) is seen at the top of an office building.

Source: Michael Vi / Shutterstock.com

Oh no! People are leaving California. Peruse the Internet and you’ll find plenty of stories about folks migrating away from the Golden State. Some of the most common reasons center on cost-of-living issues. Of course, partisan websites will pin the blame on Democrats and their liberal policies. And that would seem to put a bad light on San Diego-based Sempra (NYSE:SRE).

From an almost lifelong Californian, I have a different perspective. It seems that more people are moving in than moving out. Anybody that has driven through the 5 (or heaven forbid the 405) freeway during rush-hour traffic knows what I’m talking about. And it turns out that I’m not just suffering from observational biases.

The latest estimate calls for San Diego County’s population to peak at 3.4 million in about 20 years. That’s quite a while, which makes SRE one of the long-term dividend stocks to consider.

Right now, Sempra offers a forward yield of 3.12%. Further, the company enjoys 20 years of consecutive dividend increases. That’s pretty reliable if you ask me.

IBM (IBM)

Photo of IBM (IBM) building as seen through the canopy of a tree. IBM logo is in large letters on side of building.

Source: shutterstock.com/LCV

Here’s the thing about legacy tech juggernaut IBM (NYSE:IBM). If you’re looking for the “in” play in the innovation ecosystem, you’d probably look at Nvidia (NASDAQ:NVDA). However, Nvidia last time I checked barely pays a dividend. Plus, having gained so much in 2023, some questions exist if lightning can strike twice. So, if your priority is passive income that you can trust for years to come, IBM is worth a look.

Fundamentally, that’s because it’s relevant. Again, Nvidia and its ilk have taken the spotlight with their relevance toward generative artificial intelligence and whatnot. However, Big Blue has long conducted research and development in AI protocols. Also, it’s a stalwart in the machine learning segment. Notably, this space may reach a valuation of $204.3 billion by year’s end. And the sector could expand at a CAGR of 17.15% to 2030, resulting in market volume of $528.1 billion.

You want passive income? You’re going to get passive income with a forward yield of 4.15%. That’s well above the tech sector’s average yield of 1.37%. Plus, IBM has been on the move since late October. Therefore, it’s one of the top long-term dividend stocks to buy.

On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.

Source link

Leave a comment

Your email address will not be published. Required fields are marked *